Hikma takes on Perrigo lines
This article is powered by OTC Bulletin & The Rose Sheet
Executive Summary
Perrigo has struck a licensing and distribution agreement with Hikma, granting the Jordanian generics specialist the rights to market a range of its consumer healthcare products in the Middle East and North Africa (MENA) region.
You may also be interested in...
People On The Move: Appointments At Haleon, Hikma And ANEFP
A round-up of the latest European consumer health industry appointments: GSK adds three to Haleon's board; Hikma's chairman Darwazah becomes interim CEO as Olafsson departs; and ANEFP re-elects Bueno as president.
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.